Investing.com - GlaxoSmithKline reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline announced earnings per share of £0.256 on revenue of £9.53B. Analysts polled by Investing.com anticipated EPS of £0.2417 on revenue of £9.44B.
GlaxoSmithKline shares are up 13% from the beginning of the year and are trading at £1,627.80 , down-from-52-week-high.They are outperforming the AEX which is down 3.6% from the start of the year.
GlaxoSmithKline shares lost 0.97% in intra-day trade after the report.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar